The Changing Medical Publishing Industry: Economics, Expansion, and Equity.


Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 07 04 2023
accepted: 27 06 2023
pmc-release: 01 11 2024
medline: 27 11 2023
pubmed: 13 7 2023
entrez: 12 7 2023
Statut: ppublish

Résumé

Medical journal publishing has changed dramatically over the past decade. The shift from print to electronic distribution altered the industry's economic model. This was followed by open access mandates from funding organizations and the subsequent imposition of article processing charges on authors. The medical publishing industry is large and while there is variation across journals, it is overall highly profitable. As journals have moved to digital dissemination, advertising revenues decreased and publishers shifted some of the losses onto authors by way of article processing charges. The number of open access journals has increased substantially in recent years. The open access model presents an equity paradox; while it liberates scientific knowledge for the consumer, it presents barriers to those who produce research. This emerging "pay-to-publish" system offers advantages to authors who work in countries and at institutes with more resources. Finally, the medical publishing industry represents an unusual business model; the people who provide both the content and the external peer review receive no payment from the publisher, who generates revenue from the content. The very unusual economic model of this industry makes it vulnerable to disruptive change. The economic model of medical publishing is rapidly evolving and this will lead to disruption of the industry. These changes will accelerate dissemination of science and may lead to a shift away from lower-impact journals towards pre-print servers.

Identifiants

pubmed: 37438644
doi: 10.1007/s11606-023-08307-z
pii: 10.1007/s11606-023-08307-z
pmc: PMC10651592
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

3242-3246

Informations de copyright

© 2023. The Author(s), under exclusive licence to Society of General Internal Medicine.

Références

N Engl J Med. 2019 Mar 21;380(12):1181-1185
pubmed: 30699055
JAMA. 2002 Jun 5;287(21):2784-6
pubmed: 12038911
Res Integr Peer Rev. 2021 Nov 14;6(1):14
pubmed: 34776003
PLoS Med. 2010 Sep 21;7(9):e1000326
pubmed: 20877712
JAMA. 2020 Nov 10;324(18):1903-1905
pubmed: 33170232
JAMA Netw Open. 2022 Dec 1;5(12):e2252325
pubmed: 36516024
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):533-4
pubmed: 26555127
J R Soc Med. 2006 Apr;99(4):178-82
pubmed: 16574968
N Engl J Med. 2013 Feb 28;368(9):791-3
pubmed: 23445091
JAMA. 2023 Apr 18;329(15):1253-1254
pubmed: 36939740
Nature. 2012 Sep 13;489(7415):179
pubmed: 22972258
BMJ Open. 2021 Feb 1;11(2):e047107
pubmed: 33526505
JAMA. 2019 Jan 01;321(1):80-96
pubmed: 30620375
J Clin Epidemiol. 2016 May;73:82-6
pubmed: 26934549

Auteurs

Christopher M Booth (CM)

Departments of Oncology and Public Health Sciences, Queen's University, Kingston, Canada.

Joseph S Ross (JS)

Section of General Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, USA.
Department of Health Policy and Management, Yale School of Public Health, New Haven, USA.

Allan S Detsky (AS)

Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. allan.detsky@sinaihealth.ca.
Department of Medicine, University of Toronto, Toronto, Canada. allan.detsky@sinaihealth.ca.
Department of Medicine, Mount Sinai, Toronto, Canada. allan.detsky@sinaihealth.ca.
Hospital and University Health Network, Toronto, Canada. allan.detsky@sinaihealth.ca.
Mount Sinai Hospital, Room 429, 600 University Ave, Toronto, Ontario, M5N 2N8, Canada. allan.detsky@sinaihealth.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH